These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 448796)

  • 21. Serological studies on the etiological role of measles-like virus in subacute sclerosing panencephalitis.
    Polna I; Cendrowski W
    J Neurol; 1977 Nov; 216(4):301-10. PubMed ID: 72813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measles virus gene expression in subacute sclerosing panencephalitis.
    Baczko K; Carter MJ; Billeter M; ter Meulen V
    Virus Res; 1984 Oct; 1(7):585-95. PubMed ID: 6534032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of interferon on Vero cells persistently infected with SSPE virus and lytically infected with measles virus.
    Crespi M; Chiu MN; Schoub BD; Lyons SF
    Arch Virol; 1986; 90(1-2):87-96. PubMed ID: 3729726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measles virus polypeptide-specific antibody profile in multiple sclerosis.
    Dhib-Jalbut S; Lewis K; Bradburn E; McFarlin DE; McFarland HF
    Neurology; 1990 Mar; 40(3 Pt 1):430-5. PubMed ID: 2314583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measles antibodies and immunoglobulins in sera from patients with subacute sclerosing panencephalitis (SSPE) and from an infected ferret.
    Mehta PD; Tetley AJ; Thormar H
    J Neurol Sci; 1975 Nov; 26(3):283-94. PubMed ID: 1185233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SSPE-BIKEN: a naturally arising hemagglutination-defective mutant of measles virus.
    Breschkin AM; Morgan EM; McKimm J; Rapp F
    J Med Virol; 1979; 4(1):67-80. PubMed ID: 528985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of polypeptides in measles and SSPE virus strains.
    Rima BK; Martin SJ; Gould EA
    J Gen Virol; 1979 Mar; 42(3):603-8. PubMed ID: 430032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diversity of matrix protein in subacute sclerosing panencephalitis and measles virus-infected cells.
    Haga T; Yoshikawa Y; Yamanouchi K
    Microbiol Immunol; 1990; 34(6):543-50. PubMed ID: 1699115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimental subacute sclerosing panencephalitis: selective disappearance of measles virus matrix protein from the Central nervous system.
    Johnson KP; Norrby E; Swoveland P; Carrigan DR
    J Infect Dis; 1981 Aug; 144(2):161-9. PubMed ID: 7024431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of measles and canine distemper virus polypeptides.
    Campbell JJ; Cosby SL; Scott JK; Rima BK; Martin SJ; Appel M
    J Gen Virol; 1980 May; 48(1):149-59. PubMed ID: 6770040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody in SSPE serum and brain igG against measles virus smooth nucleocapsids detected by immunoelectron microscopy.
    Brown HR; Thormar H
    Acta Neuropathol; 1977 Oct; 40(2):183-8. PubMed ID: 337749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measles virus-specified polypeptide synthesis in two persistently infected HeLa cell lines.
    Wechsler SL; Rustigian R; Stallcup KC; Byers KB; Winston SH; Fields BN
    J Virol; 1979 Sep; 31(3):677-84. PubMed ID: 513191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell-mediated cytotoxicity against measles virus in SSPE. I. Enhancement by antibody.
    Kreth HW; Meulen V
    J Immunol; 1977 Jan; 118(1):291-5. PubMed ID: 830752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunological response of subacute sclerosing panencephalitis patients to measles virus.
    Madden DL; Fuccillo DA; Castellano G; Traub R; Krezlewicz A; Sever JL
    Neurol Neurocir Psiquiatr; 1977; 18(2-3 Suppl):509-20. PubMed ID: 616551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunologic and virologic studies of measles inclusion body encephalitis in an immunosuppressed host: the relationship to subacute sclerosing panencephalitis.
    Roos RP; Graves MC; Wollmann RL; Chilcote RR; Nixon J
    Neurology; 1981 Oct; 31(10):1263-70. PubMed ID: 7202137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gel-precipitating measles virus antibodies in subacute sclerosing panencephalitis: relation to oligoclonal IgG proteins in the cerebrospinal fluid and serum, and the occurrence of two separate fractions of antibody to virus nucleocapsids.
    Vandvik B
    Acta Pathol Microbiol Scand C; 1977 Oct; 85(5):324-32. PubMed ID: 411326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The matrix proteins of neurovirulent subacute sclerosing panencephalitis virus and its acute measles virus progenitor are functionally different.
    Hirano A; Wang AH; Gombart AF; Wong TC
    Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8745-9. PubMed ID: 1528889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Precipitation of measles virus proteins by immunoglobulin G fractions containing groups of oligoclonal bands isolated from sera of patients with subacute sclerosing panencephalitis.
    Lin FH; Mehta PD; Thormar H
    Infect Immun; 1982 Jul; 37(1):393-6. PubMed ID: 7107008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of measles virus antibodies on a measles SSPE virus persistently infected C6 rat glioma cell line.
    Barrett PN; Koschel K; Carter M; ter Meulen V
    J Gen Virol; 1985 Jul; 66 ( Pt 7)():1411-21. PubMed ID: 4020346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of defective measles virus genes in brain tissues of patients with subacute sclerosing panencephalitis.
    Baczko K; Liebert UG; Billeter M; Cattaneo R; Budka H; ter Meulen V
    J Virol; 1986 Aug; 59(2):472-8. PubMed ID: 3735490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.